Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study

Opioid use disorder (OUD) has been linked to macroscopic structural alterations in the brain. The monthly injectable, extended-release formulation of μ-opioid antagonist naltrexone (XR-NTX) is highly effective in reducing opioid craving and preventing opioid relapse. Here, we investigated the neuroanatomical effects of XR-NTX by examining changes in cortical thickness during treatment for OUD. Forty-seven OUD patients underwent structural magnetic resonance imaging and subjectively rated their opioid craving ≤1 day before (pre-treatment) and 11 ± 3 days after (on-treatment) the first XR-NTX injection. A sample of fifty-six non-OUD individuals completed a single imaging session and served as the comparison group. A publicly available [¹¹C]carfentanil positron emission tomography dataset was used to assess the relationship between changes in cortical thickness and μ-opioid receptor (MOR) binding potential across brain regions. We found that the thickness of the medial prefrontal and anterior cingulate cortices (mPFC/aCC; regions with high MOR binding potential) was comparable between the non-OUD individuals and the OUD patients at pre-treatment. However, among the OUD patients, mPFC/aCC thickness significantly decreased from pre-treatment to on-treatment. A greater reduction in mPFC/aCC thickness was associated with a greater reduction in opioid craving. Taken together, our study suggests XR-NTX-induced cortical thickness reduction in the mPFC/aCC regions in OUD patients. The reduction in thickness does not appear to indicate a restoration to the non-OUD level but rather reflects XR-NTX’s distinct therapeutic impact on an MOR-rich brain structure. Our findings highlight the neuroplastic effects of XR-NTX that may inform the development of novel OUD interventions.

• Publication year

  2024

• Venue

  Translational Psychiatry

• Publication date

  2024-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41398-024-03061-0PMID 39237534PMCID 11377591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study

  2023cited by this paper
• Effects of current smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study

  2023cited by this paper
• Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies

  2023cited by this paper
• The Neural Signature of Impaired Inhibitory Control in Individuals with Heroin Use Disorder

  2022cited by this paper
• Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia

  2022cited by this paper
• Recovery of superior frontal gyrus cortical thickness and resting‐state functional connectivity in abstinent heroin users after 8 months of follow‐up

  2022cited by this paper
• A neuromarker for drug and food craving distinguishes drug users from non-users

  2021cited by this paper
• The epidemic of fentanyl misuse and overdoses: challenges and strategies

  2021cited by this paper
• Cortical thickness abnormalities in patients with bipolar disorder: a systematic review and meta-analysis.

  2021cited by this paper
• Repeated morphine exposure activates synaptogenesis and other neuroplasticity-related gene networks in the dorsomedial prefrontal cortex of male and female rats.

  2021cited by this paper
• Mapping neurotransmitter systems to the structural and functional organization of the human neocortex

  2021cited by this paper
• The ANTsX ecosystem for quantitative biological and medical imaging

  2021cited by this paper
• Impact of Treatment Duration on Mortality Among Veterans with Opioid Use Disorder in the United States Veterans Health Administration.

  2021cited by this paper
• The influence of methadone on cerebral gray matter and functional connectivity.

  2021cited by this paper
• Cortical thickness abnormalities in patients with post-traumatic stress disorder: A vertex-based meta-analysis.

  2021cited by this paper
• Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder

  2020cited by this paper
• Brain volume changes after long‐term injectable opioid treatment: A longitudinal voxel‐based morphometry study

  2020cited by this paper
• Medication Treatment of Opioid Use Disorder.

  2020cited by this paper
• Interindividual variability and lateralization of μ-opioid receptors in the human brain

  2020cited by this paper
• Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial.

  2020cited by this paper
• Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders.

  2020cited by this paper
• Cellular correlates of cortical thinning throughout the lifespan

  2019cited by this paper
• A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

  2019cited by this paper
• Decision making of individuals with heroin addiction receiving opioid maintenance treatment compared to early abstinent users.

  2019cited by this paper
• Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

  2018cited by this paper
• Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

  2018cited by this paper
• Cell-Specific Gene-Expression Profiles and Cortical Thickness in the Human Brain

  2018cited by this paper
• Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial

  2018cited by this paper
• Neuropsychological functioning in opioid use disorder: A research synthesis and meta-analysis

  2018cited by this paper
• Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research

  2018cited by this paper
• Craving-induced effects of different drug cues on persons abstaining from heroin

  2018cited by this paper
• Evidence for Neuroplastic Compensation in the Cerebral Cortex of Persons with Depressive Illness

  2017cited by this paper
• Gray matter abnormalities in opioid-dependent patients: A neuroimaging meta-analysis

  2017cited by this paper
• Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study

  2017cited by this paper
• More pain, more gain: Blocking the opioid system boosts adaptive cognitive control.

  2017cited by this paper
• Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

  2017cited by this paper
• Cortical thickness in obsessive–compulsive disorder: Multisite mega-analysis of 780 brain scans from six centres

  2017cited by this paper
• Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

  2017cited by this paper
• Resting-State Neuroimaging and Neuropsychological Findings in Opioid Use Disorder during Abstinence: A Review

  2017cited by this paper
• Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group

  2016cited by this paper
• Goal Management Training and Mindfulness Meditation improve executive functions and transfer to ecological tasks of daily life in polysubstance users enrolled in therapeutic community treatment.

  2016cited by this paper
• Evaluating significance in linear mixed-effects models in R

  2016cited by this paper
• Restructuring reward processing with Mindfulness‐Oriented Recovery Enhancement: novel therapeutic mechanisms to remediate hedonic dysregulation in addiction, stress, and pain

  2016cited by this paper
• Intensity Inhomogeneity Correction of Structural MR Images: A Data-Driven Approach to Define Input Algorithm Parameters

  2016cited by this paper
• Cortical Thickness in Mild Traumatic Brain Injury

  2016cited by this paper
• MRIQC: Advancing the automatic prediction of image quality in MRI from unseen sites

  2016cited by this paper
• Brain Activity During Cocaine Craving and Gambling Urges: An fMRI Study

  2016cited by this paper
• Decision-making ability in current and past users of opiates: A meta-analysis.

  2016cited by this paper
• Cognitive training for substance use disorders: Neuroscientific mechanisms.

  2016cited by this paper
• Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.

  2016cited by this paper
• A multi-modal parcellation of human cerebral cortex

  2016cited by this paper
• Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence

  2016cited by this paper
• CAT-A Computational Anatomy Toolbox for the Analysis of Structural MRI Data

  2016cited by this paper
• Predicting subsequent relapse by drug‐related cue‐induced brain activation in heroin addiction: an event‐related functional magnetic resonance imaging study

  2015cited by this paper
• The effects of methadone maintenance treatment on heroin addicts with response inhibition function impairments: Evidence from event-related potentials

  2014cited by this paper
• Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis

  2014cited by this paper
• The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania: Results of a Double-Blind, Placebo-Controlled Study

  2014cited by this paper
• Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment.

  2014cited by this paper
• Abnormal cortical thickness in heroin-dependent individuals

  2014cited by this paper
• Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions.

  2014cited by this paper
• A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness

  2014cited by this paper
• Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies.

  2014cited by this paper
• Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements

  2014cited by this paper
• Extended‐release naltrexone modulates brain response to drug cues in abstinent heroin‐dependent patients

  2014cited by this paper
• Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

  2013cited by this paper
• Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?

  2013cited by this paper
• Impulsivity, cognitive function, and their relationship in heroin-dependent individuals

  2013cited by this paper
• Assessing Cue-Induced Brain Response as a Function of Abstinence Duration in Heroin-Dependent Individuals: An Event-Related fMRI Study

  2013cited by this paper
• Structural uniformity of neocortex, revisited

  2013cited by this paper
• Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.

  2013cited by this paper
• Changes in brain gray matter in abstinent heroin addicts.

  2012cited by this paper
• Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study.

  2012cited by this paper
• Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia

  2012cited by this paper
• Frontal cortex and reward-guided learning and decision-making.

  2011cited by this paper
• Frontal Cortex and Reward-Guided Learning and Decision-Making

  2011cited by this paper
• Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss

  2011cited by this paper
• Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

  2011cited by this paper
• An Open Source Multivariate Framework for n-Tissue Segmentation with Evaluation on Public Data

  2011cited by this paper
• Where in-vivo imaging meets cytoarchitectonics: The relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET

  2011cited by this paper
• Buprenorphine and Opioid Antagonism, Tolerance, and Naltrexone-Precipitated Withdrawal

  2011cited by this paper
• Common biology of craving across legal and illegal drugs – a quantitative meta‐analysis of cue‐reactivity brain response

  2011cited by this paper
• Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies

  2010cited by this paper
• Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.

  2010cited by this paper
• Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits

  2010cited by this paper
• Longitudinal changes in cortical thickness associated with normal aging

  2010cited by this paper
• N4ITK: Improved N3 Bias Correction

  2010cited by this paper
• Cognitive enhancement as a pharmacotherapy target for stimulant addiction.

  2010cited by this paper
• Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

  2009influential reference
• Dysfunctional connectivity patterns in chronic heroin users: an fMRI study.

  2009cited by this paper
• Automatic quality assessment in structural brain magnetic resonance imaging

  2009cited by this paper
• Event-related potentials in a Go/Nogo task of abnormal response inhibition in heroin addicts

  2009cited by this paper
• A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging

  2009cited by this paper
• Type I and Type II error concerns in fMRI research: re-balancing the scale.

  2009cited by this paper
• Registration based cortical thickness measurement

  2009cited by this paper
• Social cognition and the brain: A meta‐analysis

  2009cited by this paper
• Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.

  2008cited by this paper
• Naltrexone reverses age-induced cognitive deficits in rats.

  2008cited by this paper
• Impaired response inhibition function in abstinent heroin dependents: an fMRI study.

  2008cited by this paper
• Constructing inverse probability weights for marginal structural models.

  2008cited by this paper
• Measurement of signal‐to‐noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filters

  2007cited by this paper

• Early effects of oral naltrexone on craving, resting state and cue-induced brain activation in opioid use disorder: a prospective fMRI study.

  2026cites this paper
• The impact of opioids on cognitive abilities – balancing pain management and cognitive preservation: A narrative review

  2026cites this paper
• Endogenous Opiates and Behavior: 2024.

  2025cites this paper
• Astrocytes and Astrocyte-Derived Extracellular Conduits in Opiate-Mediated Neurological Disorders

  2025cites this paper
• 1H Nuclear Magnetic Resonance (NMR)-Based Metabolic Changes in Nucleus Accumbens and Medial Prefrontal Cortex Following Administration of Morphine in Mice

  2025cites this paper
• Accelerated ageing unfolds along the sensorimotor-association cortical axis in schizophrenia: multi-site study.

  2025cites this paper
• Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder

  2025cites this paper
• Neurodiversidad y Neurodidáctica en Educación Primaria: Perspectivas y Estrategias Docentes

  2025cites this paper